Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 301–400 of 1,000
Brown, B. E., Rashid, I., van Reyk, D. M., & Davies, M. J. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05699.x · Cited by 51
The physiology of cardiovascular disease and innovative liposomal platforms for therapy
Serda, R. E., Ruiz-Esparza, Flores‐Arredondo, J. H., Segura-Ibarra, Torre‐Amione, G., Blanco, E., & Ferrari, M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s30599 · Cited by 60
Hultgårdh‐Nilsson, A., & Durbeej, M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282ef77e9 · Cited by 58
Brown, B. E., Mahroof, F. M., Cook, N. L., van Reyk, D. M., & Davies, M. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0137-3 · Cited by 48
“Subendothelial entrapment of LDL [42-44] may also allow greater extents of LDL modification than observed in plasma, as a result of chronic exposure to low levels of carbonyl compounds.”
Comparative Cardiovascular Benefits of Bempedoic Acid and Statin Drugs
Lincoff, A. M., Ray, K. K., Sasiela, W. J., Haddad, T., Nicholls, S. J., Li, N., Cho, L., Mason, D., Libby, P., Goodman, S. G., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.04.048 · Cited by 36
Kijani, S., Vázquez, A. M., Levin, M. C., Borén, J., & Fogelstrand, P. (2017) · Physiological Reports · doi:10.14814/phy2.13334 · Cited by 44
“Using multicolor microscopy, we observed that apoB was located in the ECM around VSMCs and leukocytes, and adjacent to the endothelium.”
BackgroundSelf-citationBiglycan and atherosclerosis: Lessons from high cardiovascular risk conditions
Scuruchi, M., Potì, F., Rodríguez‐Carrio, J., Campo, G. M., & Mandraffino, G. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158545 · Cited by 47
“Such interaction built-up of PGs-lipoproteins aggregates in the tunica intima triggering a local inflammatory response and representing the first step in the pathobiology of ATH [7, 29, 30].”
BackgroundGoldberg, I. J., Hu, Y., Noh, H. L., Wei, J. C., Huggins, L. A., Rackmill, M. G., Hamai, H., Reid, B. N., Blaner, W. S., & Huang, L. (2008) · Diabetes · doi:10.2337/db08-0083 · Cited by 52
“Unlike Apoe / mice, which lack the ligand to allow remnant lipoproteins to interact with both the LDL receptor and LRP, Ldlr / mice have circulating VLDL remnants and even LDL (28) that contain apoE.”
BackgroundCao, R. Y., Zhang, Y., Feng, Z., Liu, S., Liu, Y., Zheng, H., & Yang, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764994 · Cited by 48
“Moreover, vascular oxidative stress plays a fundamental role in sub-endothelial retention of lowdensity lipoprotein (LDL) cholesterol, which undergoes oxidation within inflammatory macrophages eventually resulting in the accumulation of foam cells and the formation of atherosclerotic plaque (Skålén et al., 2002).”
BackgroundReview: Hypercholesterolemia-associated endothelial progenitor cell dysfunction
Pirro, M., Bagaglia, F., Paoletti, L., Razzi, R., & Mannarino, M. R. (2008) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944708094769 · Cited by 46
“Specifically, an increased delivery to and a reduced efflux of lipoproteins from the artery wall has been associated with increased endothelial injury and atherosclerosis development and progression [Skålén et al. 2002].”
InfluentialSiddiqui, M. B., Arshad, T., Patel, S. S., Lee, E., Albhaisi, S. A. M., Sanyal, A. J., Stravitz, R. T., Driscoll, C. J., Sterling, R. K., Reichman, T., et al. (2019) · Hepatology · doi:10.1002/hep.30518 · Cited by 43
“Furthermore, sdLDL particles can more readily migrate through the arterial endothelium and into the intima of the arterial wall, leading to greater propensity for intravascular plaque formation.(38,39) Within the intima, sdLDL undergoes FIg.”
BackgroundEffects of high-intensity interval training on microvascular glycocalyx and associated microRNAs
Schmitz, B., Niehues, H., Lenders, M., Thorwesten, L., Klose, A., Krüger, M., Brand, E., & Brand, S. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00751.2018 · Cited by 46
“Whereas high shear rates may improve endothelial barrier function, low shear rates and disturbed or oscillating blood flow may lead to increased permeability for macromolecules such as low-density lipoprotein (LDL), which upon subendothelial retention, is prone to oxidation (76).”
BackgroundAnimal models of human atherosclerosis: current progress
Poznyak, A. V., Silaeva, Y. Y., Orekhov, A. N., & Deykin, A. V. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209557 · Cited by 52
“The developing atherosclerotic lesion is associated with increased entry and subsequent accumulation of atherogenic lipoproteins in the sub-endothelial space of the arterial wall, the intima-media layer (6,7).”
BackgroundOkabe, S., Morimoto, Y., Ansai, T., Yoshioka, I., Tanaka, T., Taguchi, A., Kito, S., Wakasugi‐Sato, N., Oda, M., Kuroiwa, H., et al. (2008) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2007.09.013 · Cited by 43
Deng, X., Zhang, J., Liu, Y., Chen, L., & Yu, C. (2017) · Scientific Reports · doi:10.1038/srep40256 · Cited by 43
Durgin, B. G., Cherepanova, O. A., Gomez, D., Karaoli, T., Alencar, G. F., Butcher, J. T., Zhou, Y.-Q., Bendeck, M. P., Isakson, B. E., Owens, G. K., et al. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00029.2017 · Cited by 41
Adult Stem Cells in Vascular Remodeling
Wang, D., Li, L. K., Dai, T., Wang, A., & Li, S. (2017) · Theranostics · doi:10.7150/thno.19577 · Cited by 47
“Subendothelial matrix proteoglycans are thought to contribute to lipid retention in the early stages of atherosclerosis [29].”
BackgroundZimarino, M., Prati, F., Stabile, E., Pizzicannella, J., Fouad, T. M., Filippini, A., Rabozzi, R., Trubiani, O., Pizzicannella, G., & Caterina, R. D. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.047 · Cited by 42
Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
Soto, Y., Acosta, E., Delgado, L., Pérez, A., Falcón, V., Bécquer, M. A., Fraga, Á., Brito, V., Álvarez, I., Griñán, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.238659 · Cited by 41
Molecular Interactions Between Vascular Smooth Muscle Cells and Macrophages in Atherosclerosis
Beck-Joseph, J., Tabrizian, M., & Lehoux, S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.737934 · Cited by 47
“Elevated levels of cholesterol-associated apolipoprotein (apo) B are required for the development of atherosclerosis in humans and animal models (7).”
BackgroundNuclear receptors in macrophages: A link between metabolism and inflammation
Szántó, A., & Rőszer, T. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.020 · Cited by 43
Jarad, S., Gill, G. S., Amadi, P. U., Gu, H.-M., & Zhang, D. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107833 · Cited by 43
Kamato, D., Thach, L., Getachew, R., Burch, M. L., Hollenberg, M. D., Zheng, W., Little, P. J., & Osman, N. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.11.003 · Cited by 40
Evaluation of a porcine model of early aortic valve sclerosis
Sider, K. L., Zhu, C., Kwong, A. V., Mirzaei, Z., de Lange, C. F. M., & Simmons, C. A. (2014) · Cardiovascular Pathology · doi:10.1016/j.carpath.2014.05.004 · Cited by 48
“Early atherosclerotic lesions have a sequential layered formation, with the key event in their pathogenesis believed to be the subendothelial retention of atherogenic (ApoBcontaining) lipoproteins through their interaction with proteoglycans [45,46].”
BackgroundRip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation
Levin, M. C., Jirholt, P., Wramstedt, A., Johansson, M. E., Lundberg, A. M., Trajkovska, M., Ståhlman, M., Fogelstrand, P., Brisslert, M., Fogelstrand, L., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.246702 · Cited by 41
Self-citationThe -omics era: Proteomics and lipidomics in vascular research
Didangelos, A., Stegemann, C., & Mayr, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.043 · Cited by 42
Atherosclerosis: Beyond the lipid storage hypothesis. The role of autoimmunity
Cinoku, I. I., Mavragani, C. P., & Moutsopoulos, H. Μ. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13195 · Cited by 47
Parnigoni, A., Viola, M., Karousou, E. G., Rovera, S., Giaroni, C., Passi, A. G., & Vigetti, D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00061.2022 · Cited by 43
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 44
Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: Role of nitric oxide
Csont, T., Görbe, A., Bereczki, E., Szunyog, A., Aypar, E., Tóth, M. E., Varga, Z. V., Csonka, C., Fülöp, F., Sántha, M., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.013 · Cited by 39
“This is a somewhat surprising result since proteoglycans including biglycan have been suspected to play an important role in the development of atherosclerosis due to their involvement in the mechanism of subendothelial retention of low density lipoproteins by binding to apolipoprotein B [7].”
BackgroundProtein targets of oxidized phospholipids in endothelial cells
Gugiu, B. G., Mouillesseaux, K. P., Duong, V., Herzog, T., Hekimian, A., Koroniak, Ł., Vondriska, T. M., & Watson, A. D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700264-jlr200 · Cited by 44
“It is these monocytes that differentiate into macrophages within the lesion and begin to take up oxidized lipids (mostly in the form of oxidized LDL) to become foam cells, the signature inflammatory cell of the atherosclerotic lesion (6).”
BackgroundHow do macrophages sense modified low-density lipoproteins?
Chistiakov, D. A., Melnichenko, A. А., Orekhov, A. N., & Bobryshev, Y. V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.164 · Cited by 47
Goldberg, I. J. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309666 · Cited by 45
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
Stemmer, K., Finan, B., DiMarchi, R. D., Tschöp, M. H., & Müller, T. D. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.008 · Cited by 43
Molecular biology of atherosclerosis.
Mannarino, E., & Pirro, M. (2008) · PubMed Central · Cited by 39
Mangat, R., Su, J. W., Lambert, J. E., Clandinin, M. T., Wang, Y., Uwiera, R. R. E., Forbes, J. M., Vine, D. F., Cooper, M. E., Mamo, J. C. L., et al. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03138.x · Cited by 41
Thornalley, P. J., & Rabbani, N. (2011) · Free Radical Research · doi:10.3109/10715762.2010.534162 · Cited by 37
“Keywords: Glycation , oxidative stress , 3-nitrotyrosine , nitrosylation , proteomics , systems biology Abbreviations: AGE, advanced glycation endproduct; CVD, cardiovascular disease; CEL, N ε -(1-carboxyethyl)lysine; CMA, N ω -carboxymethyl-arginine; CML, N ε -carboxymethyl-lysine; 3-DG, 3-deoxyglucosone; 3DG-H, 3-de…”
BackgroundInfluentialBeilvert, A., Cormode, D. P., Chaubet, F., Briley-Saebo, K. C., Mani, V., Mulder, W. J. M., Vucic, E., Toussaint, J., Letourneur, D., & Fayad, Z. A. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22103 · Cited by 41
Glycosyltransferases, glycosylation and atherosclerosis
Pu, Q.-H., & Yu, C. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-014-9560-8 · Cited by 39
Ruuth, M. K., Lahelma, M., Luukkonen, P. K., Lorey, M. B., Qadri, S. U., Sädevirta, S., Hyötyläinen, T., Kovanen, P. T., Hodson, L., Yki‐Järvinen, H., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315766 · Cited by 42
Ason, B. L., Castro‐Perez, J. M., Tep, S., Stefanni, A. C., Tadin‐Strapps, M., Roddy, T. P., Hankemeier, T., Hubbard, B. K., Sachs, A. B., Flanagan, W. M., et al. (2011) · Lipids · doi:10.1007/s11745-011-3596-3 · Cited by 40
Dunér, P., To, F., Beckmann, K., Björkbacka, H., Fredrikson, G. N., Nilsson, J. Å., & Bengtsson, E. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr101 · Cited by 40
Kamato, D., Babaahmadi‐Rezaei, H., Getachew, R., Thach, L., Guidone, D., Osman, N., Roufogalis, B. D., Duke, C. C., Tran, V. H., Zheng, W., et al. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12060 · Cited by 37
“Hyperelongated GAG chains, due to the action of multiple growth factors and hormones, show enhanced binding to positively charged regions of apolipoproteins on LDLs.[13,14,17,38] GAG-synthesising enzymes are increased in experimental models of atherosclerosis.”
BackgroundComplement and atherosclerosis—united to the point of no return?
Torzewski, M., & Bhakdi, S. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.09.012 · Cited by 39
The Role of Protein SUMOylation in the Pathogenesis of Atherosclerosis
Dehnavi, S., Sadeghi, M., Penson, P. E., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111856 · Cited by 39
Coelewij, L., Waddington, K. E., Robinson, G., Chocano, E., McDonnell, T. C. R., Farinha, F., Peng, J., Dönnes, P., Smith, E., Croca, S. C., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315321 · Cited by 44
Protein–nanoparticle conjugates as potential therapeutic agents for the treatment of hyperlipidemia
Maximov, V. D., Reukov, V. V., Barry, J., Cochrane, C., & Vertegel, A. A. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/26/265103 · Cited by 37
Inflammation and coagulation in atherosclerosis
Krychtiuk, K. A., Kastl, S., Wojta, J., & Speidl, W. S. (2013) · Hämostaseologie · doi:10.5482/hamo-13-07-0039 · Cited by 41
“LDL particles may migrate into the intima, the innermost layer of the artery, where they are bound to proteoglycans and „trapped“ within the vessel wall making them prone to oxidative modification (13).”
BackgroundNeoatherosclerosis From a Pathologist’s Point of View
Romero, M. E., Yahagi, K., Kolodgie, F. D., & Virmani, R. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306251 · Cited by 39
“Also, we have reported markedly greater accumulated proteoglycan in DES when compared with BMS, which may serve as a possible nidus for greater lipid retention within the subendothelial spaces with secondary macrophage infiltration.(38) In the well-established rabbit model of iliofemoral artery stenting, Joner et al(2…”
BackgroundLiu, C.-Y., Zhang, H., Chen, Y., Wang, S., Chen, Z., Liu, Z., & Wang, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.602908 · Cited by 48
“ApoB is a cholesterol-carrying component of LDL with a well-known atherogenic effect on artery subendothelial lipid retention and accumulation (Skalen et al., 2002).”
BackgroundMunjral, S., Maindarkar, M. A., Ahluwalia, P., Puvvula, A., Jamthikar, A. D., Jujaray, T., Suri, N., Paul, S., Pathak, R., Saba, L., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12051234 · Cited by 43
Enhanced extracellular lipid accumulation in acidic environments
Öörni, K., & Kovanen, P. T. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000245259.63505.c2 · Cited by 40
King, A. J., Segreti, J. A., Larson, K. J., Souers, A. J., Kym, P. R., Reilly, R. M., Collins, C. A., Voorbach, M. J., Zhao, G., Mittelstadt, S. W., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.056 · Cited by 38
“These remnant lipoproteins are then taken up by macrophages to promote foam cell formation, which initiates a proinflammatory and prothrombotic cascade of events (Boyajian and Otis, 2002; Gottsater et al., 2002; Rader and Dugi, 2000; Skalen et al., 2002; Yu and Cooper, 2001).”
BackgroundHaka, A. S., Singh, R. K., Grosheva, I., Hoffner, H., Capetillo‐Zarate, E., Chin, H. F., Anandasabapathy, N., & Maxfield, F. R. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305843 · Cited by 39
“Mouse models in which the subendothelial retention of LDL is blocked develop significantly less atherosclerosis than their wild-type counterparts, with lesion area reduced by as much as 86%.(33) Thus, mechanisms of foam cell formation based on catabolism of agLDL likely have significant physiological relevance.”
BackgroundReid, D. G., Shanahan, C. M., Duer, M. J., Arroyo, L. G., Schoppet, M., Brooks, R. A., & Murray, R. C. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m026088 · Cited by 42
Steffensen, L. B., Mortensen, M. B., Kjolby, M., Hagensen, M. K., Oxvig, C., & Bentzon, J. F. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.305874 · Cited by 35
Di, X., Tang, X., & Di, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.125 · Cited by 35
Fu, Z., Zhou, E., Wang, X., Tian, M., Kong, J., Li, J., Liang, J., Niu, C., Shen, H., Dong, S., et al. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00158.2016 · Cited by 38
“The accumulation of lipids, especially low-density lipoprotein (LDL) cholesterol, in the subintimal region of the artery, is considered to play an important role in the early stage of atherogenesis (29, 35).”
BackgroundRecent advances in therapeutic targeting of inflammation in atherosclerosis
Hedin, U., & Matic, L. P. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2018.10.051 · Cited by 39
Michel, J. (2020) · Physiological Reviews · doi:10.1152/physrev.00022.2019 · Cited by 42
Macrophages in Atherosclerosis, First or Second Row Players?
Checkouri, É., Blanchard, V., & Meilhac, O. (2021) · Biomedicines · doi:10.3390/biomedicines9091214 · Cited by 43
“VSMCs also acquire a synthetic phenotype with high production of neo-synthesized ECM components such as proteoglycans, which contribute to lipid sequestration and retention in the intima [81].”
BackgroundOlgaç, U., Knight, J., Dimos Poulikakos, A., Saur, S. C., Alkadhi, H., Desbiolles, L. M., Cattin, P. C., & Kurtcuoglu, V. (2011) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2011.06.022 · Cited by 35
“Atherosclerotic plaque formation appears at the end of a chain of events that starts with subendothelial retention of low-density lipoprotein (LDL) in arterial walls, followed by LDL accumulation, LDL oxidation, entry of monocytes into the wall and subsequent formation of foam cells (Lusis, 2000; Skalen et al., 2002).”
BackgroundSpirito, M. D., Brunelli, R., Mei, G., Bertani, F. R., Ciasca, G., Greco, G., Papi, M., Arcòvito, G., Ursini, F., & Parasassi, T. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.075788 · Cited by 35
“Subendothelial retention of lipoprotein aggregates, in the form of droplets and vesicles, represents the commonly accepted paradigmatic early step in atherogenesis (1).”
BackgroundLimitations of current therapies to prevent thrombosis: a need for novel strategies
Fabre, J., & Gurney, M. E. (2009) · Molecular BioSystems · doi:10.1039/b914375k · Cited by 36
Oberoi, R., Schuett, J., Schuett, H., Koch, A., Luchtefeld, M., Grote, K., & Schieffer, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160145 · Cited by 35
“Augmented cholesterol deposition in the vascular wall and particularly subsequent oxLDL accumulation is an early key event of atherosclerotic plaque formation [1,2].”
BackgroundIchikawa, T., Kitajima, S., Liang, J., Koike, T., Wang, X., Sun, H., Okazaki, M., Morimoto, M., Shikama, H., Watanabe, T., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700102 · Cited by 36
Gajaria, T. K., Patel, D., Devkar, R. V., & Ramachandran, A. V. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1399-2 · Cited by 34
“Oxidative modification of LDL and its subsequent uptake by macrophages and their transformation into foam cells are one of the key events toward formation of atheromatous plaque and progression of atherosclerosis (Libby 2002; Skalen et al. 2002).”
BackgroundHan, Z., Hu, H., Yin, M., Yu, L., Yan, Y., Han, P., Liu, B., & Jing, B. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00685-8 · Cited by 36
“AS begins with the infiltration and retention of apolipoprotein B that contains lipoproteins in the subendothelial region of the artery, and processes with the recruitment and accumulation of inflammatory cells, extracellular matrix and lipids (Skålén et al. 2002).”
BackgroundVine, D. F., Glimm, D. R., & Proctor, S. D. (2008) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2008.05.004 · Cited by 38
Brito, V., Mellal, K., Portelance, S. G., Pérez, A., Soto, Y., deBlois, D., Ong, H., Marleau, S., & Vázquez, A. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300444 · Cited by 35
“These observations suggest that the anti-GAG antibodies generated by chP3R99 immunization may interfere with the subendothelial retention of LDL via direct binding to GAGs, which is the initiating event in atherosclerosis.(5,39) Immunoglobulin transfer experiments may provide direct evidence for the atheroprotective c…”
BackgroundMa, X., Wang, Q., Hu, X., Wang, X., Zhao, Y., Liu, X. L., Li, J., Du, Y., Wang, M., Qiu, C., et al. (2024) · Stroke · doi:10.1161/strokeaha.123.045601 · Cited by 35
“35 This phenomenon may potentially elucidate the association between high non-HDL-C and incident carotid plaques.”
Vascular Inflammation: A Novel Access Route for Nanomedicine
Molinaro, R., Boada, C., del Rosal, G. M., Hartman, K. A., Corbo, C., Andrews, E. D., Furman, N. E. T., Cooke, J. P., & Tasciotti, E. (2016) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-12-3-169 · Cited by 35
Afroz, R., Cao, Y., Rostam, M. A., Ta, H. T., Xu, S., Zheng, W., Osman, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.005 · Cited by 35
“knockout mice demonstrates the primary role of LDLs and PGs in atherogenesis (Skalen et al., 2002).”
BackgroundInfluentialImportance and Management of Dyslipidemia in the Metabolic Syndrome
Menuet, R., Lavie, C. J., & Milani, R. V. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00007 · Cited by 39
Chapman, M. J., Packard, C. J., Björnson, E., Ginsberg, H. N., & Borén, J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120529 · Cited by 39
Self-citationMelchior, J. T., Sawyer, J. K., Kelley, K. L., Shah, R., Wilson, M. D., Hantgan, R. R., & Rudel, L. L. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m039644 · Cited by 32
Woodside, D. G., Tanifum, E. A., Ghaghada, K. B., Biediger, R. J., Caivano, A. R., Starosolski, Z. A., Khounlo, S., Bhayana, S., Abbasi, S., Craft, J. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21893-x · Cited by 34
Significance of blood lipid parameters as effective markers for arteriogenic erectile dysfunction
Li, M., Ma, Z., Zhang, X., Guo, L., & Yuan, M. (2020) · Andrology · doi:10.1111/andr.12776 · Cited by 34
Zinellu, A., Pisanu, S., Zinellu, E., Lepedda, A. J., Cherchi, G. M., Sotgia, S., Carru, C., Deiana, L., & Formato, M. (2007) · Electrophoresis · doi:10.1002/elps.200600668 · Cited by 33
KOIKE, T., Liang, J., WANG, X., ICHIKAWA, T., Shiomi, M., SUN, H., Watanabe, T., Liu, G., & Fan, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.022 · Cited by 33
“Furthermore, we compared the ability of the apoBcontaining lipoproteins to bind to biglycan, a major component of proteoglycans, a process that are supposedly involved in atherogenic lipoprotein retention in the lesions [34].”
BackgroundHurt‐Camejo, E., & Camejo, G. (2018) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd5030036 · Cited by 41
Cholesterol, Cytokines and Diseases
Saggini, A., Anogeianaki, A., Maccauro, G., Tetè, S., Salini, V., Caraffa, A., Conti, F., Fulcheri, M., Galzio, R. J., & Shaik-Dasthagirisaheb, Y. B. (2011) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201102400303 · Cited by 33
Jayaraman, S., Gantz, D., & Gursky, O. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m012567 · Cited by 33
Matikainen, N., Burza, M. A., Romeo, S., Hakkarainen, A., Adiels, M., Folkersen, L., Eriksson, P., Lundbom, N., Ehrenborg, E., Orho-Melander, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079473 · Cited by 31
Self-citationJiang, H., Huang, S., Li, X., Li, X., Zhang, Y., & Chen, Z.-Y. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304405 · Cited by 31
Engineering Nanomaterials to Address Cell-Mediated Inflammation in Atherosclerosis
Allen, S. D., Liu, Y., & Scott, E. A. (2016) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-016-0012-9 · Cited by 33
“LDL is retained via ionic bonds with proteoglycans in the extracellular matrix and subjected to oxidative modifications by enzymes and reactive oxygen species [31].”
BackgroundCellular Mechanisms of Valvular Thickening in Early and Intermediate Calcific Aortic Valve Disease
Ohukainen, P., Ruskoaho, H. J., & Rysä, J. (2018) · Current Cardiology Reviews · doi:10.2174/1573403x14666180820151325 · Cited by 35
“A significant discovery supporting this concept is that if the electrical interactions between apoB primary structure and proteoglycan are removed, transgenic mice become highly resistant to atherosclerosis despite significantly elevated serum LDL levels [15].”
BackgroundZhao, T. X., Newland, S. A., & Mallat, Z. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312287 · Cited by 34
Williams, K. J., Feig, J. E., & Fisher, E. A. A. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32823bcb15 · Cited by 34
Pietrangelo, D., Lopa, C., Litterio, M., Cotugno, M., Rubattu, S. D., & Lombardi, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146791 · Cited by 37
“During the early stages of atherogenesis, LDL and other lipoproteins accumulate in the arterial wall [90].”
Vaccination against atherosclerosis: An overview
Amirfakhryan, H. (2019) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2019.07.003 · Cited by 36
A review: Pathological and molecular biological study on atherosclerosis
Liu, J., Dong, S., & Ru, Y. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.04.012 · Cited by 33
Xue, W., Jin, Q., & Wang, X. (2023) · Nutrients · doi:10.3390/nu15194214 · Cited by 37
“The deposition of LDL in the vascular wall is considered the first step in AS development [57,58].”
BackgroundYang, S. S., Li, R.-G., Qu, X., Fang, W., & Quan, Z. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.09.008 · Cited by 30
Xu, Y., Ashline, D. J., Liu, L., Tassa, C., Shaw, S. Y., Ravid, K., Layne, M. D., Reinhold, V. N., & Robbins, P. W. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053017 · Cited by 31
Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation
Nguyen, S. D., Javanainen, M., Rissanen, S., Zhao, H., Huusko, J., Kivelä, A. M., Ylä‐Herttuala, S., Navab, M., Fogelman, A. M., Vattulainen, I., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m059485 · Cited by 31
Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding
Nigro, J., Ballinger, M. L., Dilley, R. J., Jennings, G., Wight, T. N., & Little, P. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1588-z · Cited by 32
ATVB In Focus: Immunity and Atherosclerosis
Hansson, G. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000153139.83149.a2 · Cited by 30
Hua, X., Su, J., Svenungsson, E., Hurt‐Camejo, E., Jensen‐Urstad, K., Angelin, B., Båvenholm, P., & Frostegård, J. (2009) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740802541470 · Cited by 31
“Interaction with the arterial intima and binding to proteoglycans is considered to be an important early step in plaque formation (20, 25, 26).”
BackgroundLofgren, I. E., Zern, T. L., Herron, K. L., West, K. L., Sharman, M. J., Volek, J. S., Shachter, N. S., Koo, S. I., & Fernández, M. L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.019 · Cited by 35
“Evidence has shown in some female populations that it is the best parameter to predict CHD [8] because the apo B–containing lipoproteins retained in endothelial tissue are the initiators of the atherogenic plaque formation [42].”
Background
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.